# Multi-modality Imaging of Ischemia With 18F-FDG PET and CTA

> **NCT01520025** · PHASE4 · TERMINATED · sponsor: **Ottawa Heart Institute Research Corporation** · enrollment: 18 (actual)

## Conditions studied

- Myocardial Ischemia

## Interventions

- **RADIATION:** PET MPI imaging with 18F-Fluorodeoxyglucose

## Key facts

- **NCT ID:** NCT01520025
- **Lead sponsor:** Ottawa Heart Institute Research Corporation
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-12
- **Primary completion:** 2015-01
- **Final completion:** 2015-01
- **Target enrollment:** 18 (ACTUAL)
- **Why stopped:** Continued recruitment of study participants was not feasible
- **Last updated:** 2017-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01520025

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01520025, "Multi-modality Imaging of Ischemia With 18F-FDG PET and CTA". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01520025. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*